+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Biomarker Testing Services Market by Services (Biomarker Assay Development & Validation, Flow Cytometry), Techonology (Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Next-Generation Sequencing), Disease Area, Application, End-User - Forecast 2024-2030- Product Image
Global Biomarker Testing Services Market by Services (Biomarker Assay Development & Validation, Flow Cytometry), Techonology (Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Next-Generation Sequencing), Disease Area, Application, End-User - Forecast 2024-2030- Product Image
Sale

Global Biomarker Testing Services Market by Services (Biomarker Assay Development & Validation, Flow Cytometry), Techonology (Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Next-Generation Sequencing), Disease Area, Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5715912
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biomarker Testing Services Market size was estimated at USD 964.90 million in 2023, USD 1,031.96 million in 2024, and is expected to grow at a CAGR of 7.34% to reach USD 1,585.04 million by 2030.

Biomarker testing services refer to the clinical evaluation and analysis of biological markers (biomarkers) in the human body, which are indicative of normal or pathological symptoms or pharmacologic responses to a therapeutic treatment intervention. Biomarkers play a critical role in early detection, diagnosis, and monitoring the efficacy of treatments for various diseases, including cancer, cardiovascular disorders, and neurological conditions. The need for biomarker testing services is driven by the increasing incidences of genetic and chronic diseases worldwide, the growing recognition of the utility of biomarkers in personalized medicine, and advancements in biotechnology.

A supportive regulatory environment has also facilitated the approval of biomarker-based tests and therapies. However, the high costs associated with biomarker tests and the requirement for sophisticated infrastructure and technology pose significant barriers. Additionally, the lack of universally accepted standards for biomarker testing and validation processes complicates their widespread adoption in clinical settings, and technical limitations of biomarker testing raise concerns about the accuracy of the technology. However, key players are exploring advances in bioinformatics, genomics, and proteomics to enhance the accuracy and reliability of biomarker tests. Additionally, the integration of AL/ML and data analytics technologies to enhance biomarker analysis and interpretation and collaborations between academic institutions, healthcare providers, and industry players to accelerate biomarker research and application can further expand the growth of the industry.

Regional Insights

The Americas, particularly the U.S. and Canada, represent a significant market for biomarker testing services, attributed to advanced healthcare infrastructure, high healthcare expenditure, and a strong focus on research and innovation. The U.S. leads in the adoption of biomarker tests, driven by personalized healthcare trends and proactive government initiatives aiming at early disease detection and management. The region also supports numerous patents related to biomarker technology, showcasing a strong emphasis on developing more precise and predictive diagnostic tools.

EU countries are witnessing a growing adoption of biomarker testing services due to the highly developed healthcare sector and extensive research activities supported by the EU's health programs, such as Horizon Europe. The recent focus has been on oncology and neurological disorders, with numerous initiatives aimed at integrating biomarker testing into clinical practice to enable personalized treatment approaches. EU's stringent regulations pertaining to biomarker development and biomarker testing have created a standardized framework for supporting innovations in biotechnology. The Middle East shows promise due to substantial investments in healthcare infrastructure and an increasing focus on preventative care. In the APAC region, nations such as China, Japan, and India showcase innovation in biomarker testing services. The need in these countries is driven by increasing healthcare spending, rising awareness regarding personalized medicine, and the burgeoning biopharmaceutical sector. China is witnessing rapid advancements in molecular diagnostics, fueled by both government and private sector investments in research and development. Japan, renowned for its technological innovation, sees a high adoption rate of advanced biomarker tests among its aging population, aiming for early detection and treatment strategies.

Market Trends by Segment

  • Technology: Ongoing advancements to improve the versatility, speed, and amplification capabilities of polymerase chain reaction technology
  • End-User: Emerging utilization of biomarker testing services by pharmaceutical & biotechnology companies for therapeutic interventions

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Mayo Clinic Laboratories and Progentec Collaborate To Bring Advanced Biomarker Testing Services To Patients With Autoimmune Diseases

In a strategic move poised to transform autoimmune disease management, Mayo Clinic Laboratories, has teamed up with Progentec Diagnostics, an innovator in digital health and biomarker technologies. This collaboration is set to deliver Progentec's novel suite of biomarker blood tests across the U.S. and selected international markets, enhancing the accessibility of advanced diagnostic solutions for both healthcare providers and patients battling autoimmune diseases.

Novel Prostate Cancer Biomarker Test Launches on US Market

Quest Diagnostics, in collaboration with Envision Sciences, has launched an innovative prostate cancer biomarker test in the United States, a groundbreaking development aimed at enhancing the precision of prostate cancer biopsy grading. This strategic collaboration seeks to address a significant clinical need impacting millions of men in their cancer staging, diagnosis, and treatment journeys.

Quanterix Launches LucentAD Biomarker Blood Test To Aid Physician Diagnosis of Alzheimer’s Disease In Patients

Quanterix Corporation has launched its innovative LucentAD test, designed to facilitate the evaluation process for healthcare providers in diagnosing early signs of Alzheimer's disease (AD) in patients presenting cognitive symptoms. This cutting-edge test aims to streamline the process for clinicians when assessing the likelihood of amyloid pathology - an indicator of Alzheimer's disease.

Key Company Profiles

The report delves into recent significant developments in the Biomarker Testing Services Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC by Danaher Corporation, Agilent Technologies, Inc., Avid Bioservices, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, BiomarkerBay B. V., Bristol Myers Squibb, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Icon PLC, Intertek Group PLC, IQVIA, JSR Life Sciences, LLC, KCAS Group, Laboratory Corporation of America Holdings, LGC Group, Merck KGaA, Myriad Genetics, Inc., NeoGenomics Laboratories, Parexel International Corporation, PerkinElmer Inc., Randox Laboratories, SGS S.A., Shuwen Biotech Co., Ltd., Syneos Health, Thermo Fisher Scientific, Inc., and WuXi Biologics Inc.

This research report offers invaluable insights into various crucial aspects of the Biomarker Testing Services Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cancer drug development and need for high-performing biomarkers
5.1.1.2. Government initiatives and investments for biomarker research
5.1.1.3. Improved availability of financial coverage for biomarker testing
5.1.2. Restraints
5.1.2.1. Time-consuming and expensive process of biomarker testing
5.1.3. Opportunities
5.1.3.1. Advancements in biomarker testing tools & equipment with AI & ML
5.1.3.2. Emerging CDMOs offering biomarker testing and analysis services
5.1.4. Challenges
5.1.4.1. Barriers in testing due to lack of sample collection and authenticity
5.2. Market Segmentation Analysis
5.2.1. Technology: Ongoing advancements to improve the versatility, speed, and amplification capabilities of polymerase chain reaction technology
5.2.2. End-User: Emerging utilization of biomarker testing services by pharmaceutical & biotechnology companies for therapeutic interventions
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Biomarker Testing Services Market, by Services
6.1. Introduction
6.2. Biomarker Assay Development & Validation
6.3. Flow Cytometry
7. Biomarker Testing Services Market, by Techonology
7.1. Introduction
7.2. Enzyme-Linked Immunosorbent Assay
7.3. Mass Spectrometry
7.4. Next-Generation Sequencing
7.5. Polymerase Chain Reaction
8. Biomarker Testing Services Market, by Disease Area
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cancer
8.4. Cardiovascular Diseases
8.5. Neurological Disorders
9. Biomarker Testing Services Market, by Application
9.1. Introduction
9.2. Drug Mechanism of Action
9.3. Pharmacodynamic
9.4. Predictive Clinical Studies
9.5. Prognostic
10. Biomarker Testing Services Market, by End-User
10.1. Introduction
10.2. Contract Research Oraganizations
10.3. Pharmaceutical & biotechnology companies
10.4. Research Institutes
11. Americas Biomarker Testing Services Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Biomarker Testing Services Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Biomarker Testing Services Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Mayo Clinic Laboratories and Progentec Collaborate To Bring Advanced Biomarker Testing Services To Patients With Autoimmune Diseases
14.3.2. Novel Prostate Cancer Biomarker Test Launches on US Market
14.3.3. Quanterix Launches LucentAD Biomarker Blood Test To Aid Physician Diagnosis of Alzheimer’s Disease In Patients
14.4. Strategy Analysis & Recommendation
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. BIOMARKER TESTING SERVICES MARKET RESEARCH PROCESS
FIGURE 2. BIOMARKER TESTING SERVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOMARKER TESTING SERVICES MARKET DYNAMICS
FIGURE 7. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
FIGURE 8. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2023 VS 2030 (%)
FIGURE 12. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. BIOMARKER TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. BIOMARKER TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BIOMARKER TESTING SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY BIOMARKER ASSAY DEVELOPMENT & VALIDATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY BIOMARKER ASSAY DEVELOPMENT & VALIDATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DRUG MECHANISM OF ACTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DRUG MECHANISM OF ACTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACODYNAMIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACODYNAMIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PREDICTIVE CLINICAL STUDIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PREDICTIVE CLINICAL STUDIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PROGNOSTIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PROGNOSTIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORAGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORAGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 83. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 84. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 85. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 86. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 87. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 88. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 89. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 94. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 95. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 96. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 97. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 98. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 99. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 102. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 118. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 124. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 126. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 127. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 128. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 129. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 130. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 131. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 132. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 133. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 134. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 135. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 138. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 139. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 140. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 141. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 142. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 143. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 148. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 149. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 150. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 151. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 152. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 153. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 156. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 157. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 158. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 159. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 160. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 161. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 162. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 163. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 168. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 169. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 170. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 171. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 172. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 173. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 176. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 177. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 178. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 179. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 180. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 181. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 182. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 183. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 188. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 189. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 190. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 191. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 192. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 193. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 196. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 197. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 198. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 199. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 200. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 201. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 202. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 203. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 206. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 207. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 208. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 209. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 210. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 211. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 212. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 213. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 214. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 215. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 216. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 217. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 218. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 219. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 220. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 221. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 222. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 223. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 226. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 227. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 228. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 229. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 230. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 231. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 232. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 233. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 236. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 237. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 238. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 239. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 240. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 241. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 242. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 243. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 246. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 259. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 260. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 261. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 262. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 263. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 264. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 265. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 270. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 271. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 272. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 273. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 274. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 275. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 278. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 279. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 280. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 281. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 282. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 283. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 284. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 285. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 286. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 287. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 288. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 289. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 290. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 291. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 292. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 293. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 294. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 295. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 296. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 297. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 298. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 299. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 300. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 301. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 302. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 303. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 304. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 305. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 306. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 307. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 308. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 309. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 310. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 311. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 312. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 313. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 314. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 315. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 316. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 317. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 318. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 319. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 320. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 321. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
TABLE 322. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
TABLE 323. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
TABLE 324. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
TABLE 325. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY A

Companies Mentioned

  • Abcam PLC by Danaher Corporation
  • Agilent Technologies, Inc.
  • Avid Bioservices, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioAgilytix Labs
  • BiomarkerBay B. V.
  • Bristol Myers Squibb
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Icon PLC
  • Intertek Group PLC
  • IQVIA
  • JSR Life Sciences, LLC
  • KCAS Group
  • Laboratory Corporation of America Holdings
  • LGC Group
  • Merck KGaA
  • Myriad Genetics, Inc.
  • NeoGenomics Laboratories
  • Parexel International Corporation
  • PerkinElmer Inc.
  • Randox Laboratories
  • SGS S.A.
  • Shuwen Biotech Co., Ltd.
  • Syneos Health
  • Thermo Fisher Scientific, Inc.
  • WuXi Biologics Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.03 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.58 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Cardiac Biomarkers Testing Global Market Report 2024 - Product Image

Cardiac Biomarkers Testing Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global PD-L1 Biomarker Testing Market (2023 Edition): Analysis By Cancer Type (NSCLC, Kidney Cancer, Melanoma, Head and Neck, Bladder Cancer, Others), Assay Kit Type, End Use, By Region, By Country: Market Insights and Forecast (2019-2029) - Product Image

Global PD-L1 Biomarker Testing Market (2023 Edition): Analysis By Cancer Type (NSCLC, Kidney Cancer, Melanoma, Head and Neck, Bladder Cancer, Others), Assay Kit Type, End Use, By Region, By Country: Market Insights and Forecast (2019-2029)

  • Report
  • 270 Pages
  • Global
From
Cardiac Biomarkers Testing Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 - Product Image

Cardiac Biomarkers Testing Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

  • Report
  • 150 Pages
  • Global
From
Metabolic Biomarker Testing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Metabolic Biomarker Testing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 87 Pages
  • Global
From
PD-L1 Biomarker Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

PD-L1 Biomarker Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 178 Pages
  • Global
From

About the Diagnostic Biomarker Market

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases. Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition. The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.